Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution

Kobayashi, Shinta, Yamada‐Okabe, Hisafumi, Suzuki, Masami, Natori, Osamu, Kato, Atsuhiko, Matsubara, Koichi, Jau Chen, Yu, Yamazaki, Masaki, Funahashi, Shinichi, Yoshida, Kenji, Hashimoto, Eri, Watanabe, Yoshinori, Mutoh, Hironori, Ashihara, Motooki, Kato, Chie, Watanabe, Takeshi, Yoshikubo, Takashi, Tamaoki, Norikazu, Ochiya, Takahiro, Kuroda, Masahiko, Levine, Arnold J., Yamazaki, Tatsumi·2012·STEM CELLS

Abstract

The cancer stem cell (CSC) concept has been proposed as an attractive theory to explain cancer development, and CSCs themselves have been considered as targets for the development of diagnostics and therapeutics. However, many unanswered questions concerning the existence of slow cycling/quiescent, drug-resistant CSCs remain. Here we report the establishment of colon cancer CSC lines, interconversion of the CSCs between a proliferating and a drug-resistant state, and reconstitution of tumor hierarchy from the CSCs. Stable cell lines having CSC properties were established from human colon cancer after serial passages in NOD/Shi-scid, IL-2Rγ(null) (NOG) mice and subsequent adherent cell culture of these tumors. By generating specific antibodies against LGR5, we demonstrated that these cells expressed LGR5 and underwent self-renewal using symmetrical divisions. Upon exposure to irinotecan, the LGR5(+) cells transitioned into an LGR5(-) drug-resistant state. The LGR5(-) cells converted to an LGR5(+) state in the absence of the drug. DNA microarray analysis and immunohistochemistry demonstrated that HLA-DMA was specifically expressed in drug-resistant LGR5(-) cells, and epiregulin was expressed in both LGR5(+) and drug-resistant LGR5(-) cells. Both cells sustained tumor initiating activity in NOG mice, giving rise to a tumor tissue hierarchy. In addition, anti-epiregulin antibody was found to be efficacious in a metastatic model. Both LGR5(+) and LGR5(-) cells were detected in the tumor tissues of colon cancer patients. The results provide new biological insights into drug resistance of CSCs and new therapeutic options for cancer treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/stem.1257

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 175

Metadata

Authors
Kobayashi, S., Yamada‐Okabe, H., Suzuki, M., Natori, O., Kato, A., Matsubara, K., Jau Chen, Y., Yamazaki, M., Funahashi, S., Yoshida, K., Hashimoto, E., Watanabe, Y., Mutoh, H., Ashihara, M., Kato, C., Watanabe, T., Yoshikubo, T., Tamaoki, N., Ochiya, T., Kuroda, M., Levine, A. J., & Yamazaki, T.
Venue
STEM CELLS
Published
2012-11-27
Volume
30
Issue
12
Pages
2631-2644
ISSN
  • 1066-5099 (ISSN-L)
  • 1549-4918
OpenAlex
W2082080609
Cited by
175
References
4
FWCI
6.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution. https://app.cochat.ai/papers/10.1002/stem.1257
The paper
Kobayashi, S., Yamada‐Okabe, H., Suzuki, M., Natori, O., Kato, A., Matsubara, K., Jau Chen, Y., Yamazaki, M., Funahashi, S., Yoshida, K., Hashimoto, E., Watanabe, Y., Mutoh, H., Ashihara, M., Kato, C., Watanabe, T., Yoshikubo, T., Tamaoki, N., Ochiya, T., . . . Yamazaki, T. (2012). LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution. STEM CELLS. https://doi.org/10.1002/stem.1257

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.